Janssen Biotech, Inc. v. Abbott Laboratories
565 U.S. 1197, 182 L. Ed. 2d 162, 132 S. Ct. 1542, 80 U.S.L.W. 3472, 2012 WL 538345, 2012 U.S. LEXIS 1535
This text of 565 U.S. 1197 (Janssen Biotech, Inc. v. Abbott Laboratories) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Janssen Biotech, Inc. v. Abbott Laboratories, 565 U.S. 1197, 182 L. Ed. 2d 162, 132 S. Ct. 1542, 80 U.S.L.W. 3472, 2012 WL 538345, 2012 U.S. LEXIS 1535 (2012).
Opinion
C. A. 3d Cir. Certiorari denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
565 U.S. 1197, 182 L. Ed. 2d 162, 132 S. Ct. 1542, 80 U.S.L.W. 3472, 2012 WL 538345, 2012 U.S. LEXIS 1535, Counsel Stack Legal Research, https://law.counselstack.com/opinion/janssen-biotech-inc-v-abbott-laboratories-scotus-2012.